PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS

Abstract: pharmacoeconomic study of treatment primary open-angle glaucoma with fix combination of carbonic anhydrise inhibitors and betablockers by mean of cost-utility, willingness-to-pay, cost minimization and budget impact analysis was conducted. Results have shown, that Azarga has benefits compa...

Full description

Bibliographic Details
Main Author: M. V. Protsenko
Format: Article
Language:Russian
Published: IRBIS LLC 2015-03-01
Series:Фармакоэкономика
Subjects:
primary open-angle glaucoma
pharmacoeconomic studies
cost-utility analysis
willingness-to-pay analysis
cost minimization analysis
budget impact analysis
timolol
brinzolamid
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/38

Internet

https://www.pharmacoeconomics.ru/jour/article/view/38

Similar Items